fifteen asthmatic outpatients were randomly treated during two periods of 14 days each with sustained-release preparations of either enprofylline ( 3-propyl-xanthine ) or theophylline ( theo-dur ) in a double-blind crossover study .
C0004096
asthmatic
C0039771
theophylline